{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:06:36Z","timestamp":1790179596632,"version":"4.1.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-025-03321-7","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T22:20:58Z","timestamp":1743027658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Shared early molecular mechanisms revealed in P301S and 5xFAD Alzheimer\u2019s disease mouse models"],"prefix":"10.1038","volume":"15","author":[{"given":"Huda","family":"Suloh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank Kumar","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Kartawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajeha","family":"Hamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish Kumar","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wisam","family":"Bazbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nofar","family":"Schottlender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Ashery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2278-5892","authenticated-orcid":false,"given":"Igor","family":"Khaliulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8380-2054","authenticated-orcid":false,"given":"Haitham","family":"Amal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"3321_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-021-01578-2","volume":"11","author":"S Mencer","year":"2021","unstructured":"Mencer S, Kartawy M, Lendenfeld F, Soluh H, Tripathi MK, Khaliulin I, et al. Proteomics of autism and Alzheimer\u2019s mouse models reveal common alterations in mTOR signaling pathway. Transl Psychiatry. 2021;11:1\u201310.","journal-title":"Transl Psychiatry"},{"key":"3321_CR2","doi-asserted-by":"publisher","first-page":"101567","DOI":"10.1016\/j.redox.2020.101567","volume":"34","author":"MK Tripathi","year":"2020","unstructured":"Tripathi MK, Kartawy M, Amal H. The role of nitric oxide in brain disorders: autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders. Redox Biol. 2020;34:101567.","journal-title":"Redox Biol"},{"key":"3321_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clinbiochem.2019.04.015","volume":"72","author":"M Zv\u011b\u0159ov\u00e1","year":"2019","unstructured":"Zv\u011b\u0159ov\u00e1 M. Clinical aspects of Alzheimer\u2019s disease. Clin Biochem. 2019;72:3\u20136.","journal-title":"Clin Biochem"},{"key":"3321_CR4","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1046\/j.1532-5415.2002.50265.x","volume":"50","author":"G Kuslansky","year":"2002","unstructured":"Kuslansky G, Buschke H, Katz M, Sliwinski M, Lipton RB. Screening for Alzheimer\u2019s disease: the memory impairment screen versus the conventional three\u2010word memory test. J Am Geriatrics Soc. 2002;50:1086\u201391.","journal-title":"J Am Geriatrics Soc"},{"key":"3321_CR5","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20209819","volume":"16","author":"N Morshed","year":"2020","unstructured":"Morshed N, Ralvenius WT, Nott A, Watson LA, Rodriguez FH, Akay LA, et al. Phosphoproteomics identifies microglial Siglec\u2010F inflammatory response during neurodegeneration. Mol Syst Biol. 2020;16:e9819.","journal-title":"Mol Syst Biol"},{"key":"3321_CR6","unstructured":"Jahn H. Memory loss in Alzheimer\u2019s disease. Dialogues Clin Neurosci 2022."},{"key":"3321_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12017-009-8097-7","volume":"12","author":"JJ Palop","year":"2010","unstructured":"Palop JJ, Mucke L. Synaptic depression and aberrant excitatory network activity in Alzheimer\u2019s disease: two faces of the same coin? Neuromolecular Med. 2010;12:48\u201355.","journal-title":"Neuromolecular Med"},{"key":"3321_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1006\/neur.1996.0057","volume":"5","author":"DM Mann","year":"1996","unstructured":"Mann DM. Pyramidal nerve cell loss in Alzheimer\u2019s disease. Neurodegeneration. 1996;5:423\u20137.","journal-title":"Neurodegeneration"},{"key":"3321_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"M Goedert","year":"2006","unstructured":"Goedert M, Spillantini MG. A century of Alzheimer\u2019s disease. Science. 2006;314:777\u201381.","journal-title":"Science"},{"key":"3321_CR10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"G Chen","year":"2017","unstructured":"Chen G, Xu T, Yan Y, Zhou Y-R, Jiang Y, Melcher K, Xu HE. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacologica Sin. 2017;38:1205\u201335.","journal-title":"Acta Pharmacologica Sin"},{"key":"3321_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2214\/ajr.182.1.1820003","volume":"182","author":"JF Norfray","year":"2004","unstructured":"Norfray JF, Provenzale JM. Alzheimer\u2019s disease: neuropathologic findings and recent advances in imaging. Am J Roentgenology. 2004;182:3\u201313.","journal-title":"Am J Roentgenology"},{"key":"3321_CR12","first-page":"24","volume":"4","author":"IO Korolev","year":"2014","unstructured":"Korolev IO. Alzheimer\u2019s disease: a clinical and basic science review. Med Stud Res J. 2014;4:24\u201333.","journal-title":"Med Stud Res J"},{"key":"3321_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/B978-0-12-385883-2.00008-4","volume":"107","author":"L Bertram","year":"2012","unstructured":"Bertram L, Tanzi RE. The genetics of Alzheimer\u2019s disease. Prog Mol Biol Transl Sci. 2012;107:79\u2013100.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3321_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainresbull.2011.11.017","volume":"88","author":"AM Hall","year":"2012","unstructured":"Hall AM, Roberson ED. Mouse models of Alzheimer\u2019s disease. Brain Res Bull. 2012;88:3\u201312.","journal-title":"Brain Res Bull"},{"key":"3321_CR15","doi-asserted-by":"publisher","first-page":"e1002270","DOI":"10.1371\/journal.pmed.1002270","volume":"14","author":"HM Lanoisel\u00e9e","year":"2017","unstructured":"Lanoisel\u00e9e HM, Nicolas G, Wallon D, Rovelet-Lecrux A, Lacour M, Rousseau S, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med. 2017;14:e1002270.","journal-title":"PLoS Med"},{"key":"3321_CR16","doi-asserted-by":"publisher","first-page":"20935","DOI":"10.18632\/aging.203485","volume":"13","author":"R Shapira","year":"2021","unstructured":"Shapira R, Gdalyahu A, Gottfried I, Sasson E, Hadanny A, et al. Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer\u2019s disease mouse model and in elderly patients. Aging (Albany NY). 2021;13:20935\u201361.","journal-title":"Aging (Albany NY)"},{"key":"3321_CR17","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"3321_CR18","doi-asserted-by":"publisher","first-page":"114105","DOI":"10.1016\/j.biopha.2022.114105","volume":"158","author":"IG Ju","year":"2023","unstructured":"Ju IG, Son SY, Lee S, Im H, Huh E, Eo H, et al. Protective effects of CCL01 against A\u03b2-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer\u2019s disease. Biomedicine Pharmacotherapy. 2023;158:114105.","journal-title":"Biomedicine Pharmacotherapy"},{"key":"3321_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81304-6","volume":"11","author":"J Shin","year":"2021","unstructured":"Shin J, Park S, Lee H, Kim Y. Thioflavin-positive tau aggregates complicating quantification of amyloid plaques in the brain of 5XFAD transgenic mouse model. Sci Rep. 2021;11:1617.","journal-title":"Sci Rep"},{"key":"3321_CR20","doi-asserted-by":"publisher","first-page":"106427","DOI":"10.1016\/j.nbd.2024.106427","volume":"192","author":"M Kourti","year":"2024","unstructured":"Kourti M, Metaxas A. A systematic review and meta-analysis of tau phosphorylation in mouse models of familial Alzheimer\u2019s disease. Neurobiol Dis. 2024;192:106427.","journal-title":"Neurobiol Dis"},{"key":"3321_CR21","unstructured":"Morshed NF. Phosphoproteomics analysis of Alzheimer\u2019s disease: Massachusetts Institute of Technology; 2021."},{"key":"3321_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-019-0388-7","volume":"9","author":"H Amal","year":"2019","unstructured":"Amal H, Gong G, Gjoneska E, Lewis SM, Wishnok JS, Tsai LH, et al. S-nitrosylation of E3 ubiquitin-protein ligase RNF213 alters non-canonical Wnt\/Ca+ 2 signaling in the P301S mouse model of tauopathy. Transl Psychiatry. 2019;9:1\u201312.","journal-title":"Transl Psychiatry"},{"key":"3321_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B, Huang S, Iwata N, Saido TC, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53:337\u201351.","journal-title":"Neuron"},{"key":"3321_CR24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fncel.2015.00322","volume":"9","author":"JE Yuste","year":"2015","unstructured":"Yuste JE, Tarragon E, Campuzano CM, Ros-Bernal F. Implications of glial nitric oxide in neurodegenerative diseases. Front Cell Neurosci. 2015;9:322.","journal-title":"Front Cell Neurosci"},{"key":"3321_CR25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/00019052-199512000-00016","volume":"8","author":"JB Schulz","year":"1995","unstructured":"Schulz JB, Matthews RT, Beal MF. Role of nitric oxide in neurodegenerative diseases. Curr Opin Neurol. 1995;8:480\u20136.","journal-title":"Curr Opin Neurol"},{"key":"3321_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2741\/1541","volume":"10","author":"B Zhao","year":"2005","unstructured":"Zhao B. Nitric oxide in neurodegenerative diseases. Front Bioscience-Landmark. 2005;10:454\u201361.","journal-title":"Front Bioscience-Landmark"},{"key":"3321_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.niox.2023.09.003","volume":"140","author":"M Abdel-Haq","year":"2023","unstructured":"Abdel-Haq M, Ojha SK, Hamoudi W, Kumar A, Tripathi MK, Khaliulin I, et al. Effects of extended-release 7-nitroindazole gel formulation treatment on the behavior of Shank3 mouse model of autism. Nitric Oxide. 2023;140:41\u20139.","journal-title":"Nitric Oxide"},{"key":"3321_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s12031-023-02166-3","volume":"73","author":"D Kruglyakov","year":"2023","unstructured":"Kruglyakov D, Ojha SK, Kartawy M, Tripathi MK, Hamoudi W, Bazbaz W, et al. Nitric Oxide Synthase Inhibition Prevents Cell Proliferation in Glioblastoma. J Mol Neurosci. 2023;73:875\u201383.","journal-title":"J Mol Neurosci"},{"key":"3321_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.freeradbiomed.2022.11.035","volume":"194","author":"JR Steinert","year":"2023","unstructured":"Steinert JR, Amal H. The contribution of an imbalanced redox signalling to neurological and neurodegenerative conditions. Free Radic Biol Med. 2023;194:71\u201383.","journal-title":"Free Radic Biol Med"},{"key":"3321_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01890-5","volume":"12","author":"MK Tripathi","year":"2022","unstructured":"Tripathi MK, Kartawy M, Ginzburg S, Amal H. Arsenic alters nitric oxide signaling similar to autism spectrum disorder and Alzheimer\u2019s disease-associated mutations. Transl Psychiatry. 2022;12:127.","journal-title":"Transl Psychiatry"},{"key":"3321_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205783","volume":"10","author":"MK Tripathi","year":"2023","unstructured":"Tripathi MK, Ojha SK, Kartawy M, Hamoudi W, Choudhary A, Stern S, et al. The NO answer for autism spectrum disorder. Adv Sci. 2023;10:2205783.","journal-title":"Adv Sci"},{"key":"3321_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50248-4","volume":"14","author":"MK Tripathi","year":"2024","unstructured":"Tripathi MK, Ojha SK, Kartawy M, Khaliulin I, Hamoudi W, Amal H. Mutations associated with autism lead to similar synaptic and behavioral alterations in both sexes of male and female mouse brain. Sci Rep. 2024;14:10.","journal-title":"Sci Rep"},{"key":"3321_CR33","doi-asserted-by":"publisher","first-page":"eade0764","DOI":"10.1126\/sciadv.ade0764","volume":"8","author":"H Yang","year":"2022","unstructured":"Yang H, Oh C, Amal H, Wishnok JS, Lewis S, Schahrer E, et al. Mechanistic insight into female predominance in Alzheimer\u2019s disease based on aberrant protein S-nitrosylation of C3. Sci Adv. 2022;8:eade0764.","journal-title":"Sci Adv"},{"key":"3321_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.freeradbiomed.2022.06.007","volume":"188","author":"W Hamoudi","year":"2022","unstructured":"Hamoudi W, Tripathi MK, Ojha SK, Amal H. A cross-talk between nitric oxide and the glutamatergic system in a Shank3 mouse model of autism. Free Radic Biol Med. 2022;188:83\u201391.","journal-title":"Free Radic Biol Med"},{"key":"3321_CR35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12031-024-02270-y","volume":"74","author":"W Bazbaz","year":"2024","unstructured":"Bazbaz W, Kartawy M, Hamoudi W, Ojha SK, Khaliulin I, Amal H. The Role of Thioredoxin System in Shank3 Mouse Model of Autism. J Mol Neurosci. 2024;74:90.","journal-title":"J Mol Neurosci"},{"key":"3321_CR36","first-page":"4","volume":"1","author":"SK Ojha","year":"2024","unstructured":"Ojha SK, Amal H. Air pollution: an emerging risk factor for autism spectrum disorder. Brain. 2024;1:4.","journal-title":"Brain"},{"key":"3321_CR37","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1016\/j.neuron.2024.10.013","volume":"112","author":"C Oh","year":"2024","unstructured":"Oh C, Nakamura T, Zhang X, Lipton SA. Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer\u2019s and related dementias. Neuron. 2024;112:3823\u201350.","journal-title":"Neuron"},{"key":"3321_CR38","doi-asserted-by":"publisher","first-page":"eaaw0843","DOI":"10.1126\/science.aaw0843","volume":"371","author":"T Nakamura","year":"2021","unstructured":"Nakamura T, Oh C, Liao L, Zhang X, Lopez KM, Gibbs D, et al. Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer\u2019s disease. Science. 2021;371:eaaw0843.","journal-title":"Science"},{"key":"3321_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","volume":"124","author":"S Wullschleger","year":"2006","unstructured":"Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124:471\u201384.","journal-title":"Cell"},{"key":"3321_CR40","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1111\/j.1582-4934.2008.00509.x","volume":"12","author":"JJ Pei","year":"2008","unstructured":"Pei JJ, Hugon J. mTOR\u2010dependent signalling in Alzheimer\u2019s disease. J Cell Mol Med. 2008;12:2525\u201332.","journal-title":"J Cell Mol Med"},{"key":"3321_CR41","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.freeradbiomed.2021.04.025","volume":"169","author":"M Perluigi","year":"2021","unstructured":"Perluigi M, Di Domenico F, Barone E, Butterfield D. mTOR in Alzheimer disease and its earlier stages: links to oxidative damage in the progression of this dementing disorder. Free Radic Biol Med. 2021;169:382\u201396.","journal-title":"Free Radic Biol Med"},{"key":"3321_CR42","doi-asserted-by":"publisher","first-page":"e14463","DOI":"10.1111\/cns.14463","volume":"30","author":"S Davoody","year":"2024","unstructured":"Davoody S, Asgari Taei A, Khodabakhsh P, Dargahi L. mTOR signaling and Alzheimer\u2019s disease: what we know and where we are? CNS Neurosci Therapeutics. 2024;30:e14463.","journal-title":"CNS Neurosci Therapeutics"},{"key":"3321_CR43","doi-asserted-by":"publisher","first-page":"1366061","DOI":"10.3389\/fphar.2024.1366061","volume":"15","author":"PL Xie","year":"2024","unstructured":"Xie PL, Zheng MY, Han R, Chen WX, Mao JH. Pharmacological mTOR inhibitors in ameliorating Alzheimer\u2019s disease: current review and perspectives. Front Pharmacology. 2024;15:1366061.","journal-title":"Front Pharmacology"},{"key":"3321_CR44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0002-9440(10)63687-5","volume":"163","author":"WL An","year":"2003","unstructured":"An WL, Cowburn RF, Li L, Braak H, Alafuzoff I, Iqbal K, et al. Up-regulation of phosphorylated\/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer\u2019s disease. Am J Pathol. 2003;163:591\u2013607.","journal-title":"Am J Pathol"},{"key":"3321_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1471-4159.2004.02949.x","volume":"93","author":"RJ Griffin","year":"2005","unstructured":"Griffin RJ, Moloney A, Kelliher M, Johnston JA, Ravid R, Dockery P, et al. Activation of Akt\/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer\u2019s disease pathology. J Neurochemistry. 2005;93:105\u201317.","journal-title":"J Neurochemistry"},{"key":"3321_CR46","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1038\/s41380-018-0113-6","volume":"25","author":"H Amal","year":"2020","unstructured":"Amal H, Barak B, Bhat V, Gong G, Joughin BA, Wang X, et al. Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function. Mol Psychiatry. 2020;25:1835\u201348.","journal-title":"Mol Psychiatry"},{"key":"3321_CR47","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1073\/pnas.1521318113","volume":"113","author":"U Seneviratne","year":"2016","unstructured":"Seneviratne U, Nott A, Bhat VB, Ravindra KC, Wishnok JS, Tsai LH, et al. S-nitrosation of proteins relevant to Alzheimer\u2019s disease during early stages of neurodegeneration. Proc Natl Acad Sci. 2016;113:4152\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"3321_CR48","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber J, Mann M, Ishihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc. 2007;2:1896\u2013906.","journal-title":"Nat Protoc"},{"key":"3321_CR49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Society: Ser B (Methodol). 1995;57:289\u2013300.","journal-title":"J R Stat Society: Ser B (Methodol)"},{"key":"3321_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.expneurol.2007.10.008","volume":"210","author":"K Parameshwaran","year":"2008","unstructured":"Parameshwaran K, Dhanasekaran M, Suppiramaniam V. Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp Neurol. 2008;210:7\u201313.","journal-title":"Exp Neurol"},{"key":"3321_CR51","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1080\/00207454.2020.1713776","volume":"130","author":"M Bandookwala","year":"2020","unstructured":"Bandookwala M, Sengupta P. 3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases. Int J Neurosci. 2020;130:1047\u201362.","journal-title":"Int J Neurosci"},{"key":"3321_CR52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/exnr.1999.7196","volume":"160","author":"MD Ikonomovic","year":"1999","unstructured":"Ikonomovic MD, Mizukami K, Warde D, Sheffield R, Hamilton R, Wenthold RJ, et al. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer\u2019s disease. Exp Neurol. 1999;160:194\u2013204.","journal-title":"Exp Neurol"},{"key":"3321_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pneurobio.2005.06.001","volume":"76","author":"F Guix","year":"2005","unstructured":"Guix F, Uribesalgo I, Coma M, Munoz F. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol. 2005;76:126\u201352.","journal-title":"Prog Neurobiol"},{"key":"3321_CR54","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.bbadis.2018.11.007","volume":"1865","author":"P Pic\u00f3n-Pag\u00e8s","year":"2019","unstructured":"Pic\u00f3n-Pag\u00e8s P, Garcia-Buendia J, Munoz FJ. Functions and dysfunctions of nitric oxide in brain. Biochimica et Biophysica Acta -Molecular Basis Dis. 2019;1865:1949\u201367.","journal-title":"Biochimica et Biophysica Acta -Molecular Basis Dis"},{"key":"3321_CR55","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4103\/NRR.NRR-D-23-01353","volume":"20","author":"X Zhang","year":"2025","unstructured":"Zhang X, Chen Z, Xiong Y, Zhou Q, Zhu LQ, Liu D. The emerging role of nitric oxide in the synaptic dysfunction of vascular dementia. Neural Regeneration Res. 2025;20:402\u201315.","journal-title":"Neural Regeneration Res"},{"key":"3321_CR56","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/brainsci11060677","volume":"11","author":"M Kartawy","year":"2021","unstructured":"Kartawy M, Khaliulin I, Amal H. Systems biology reveals S-Nitrosylation-dependent regulation of mitochondrial functions in mice with Shank3 mutation associated with autism spectrum disorder. Brain Sci. 2021;11:677.","journal-title":"Brain Sci"},{"key":"3321_CR57","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/1073858410366481","volume":"16","author":"JR Steinert","year":"2010","unstructured":"Steinert JR, Chernova T, Forsythe ID. Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist. 2010;16:435\u201352.","journal-title":"Neuroscientist"},{"key":"3321_CR58","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.bbagen.2011.07.010","volume":"1820","author":"N Shahani","year":"2012","unstructured":"Shahani N, Sawa A. Protein S-nitrosylation: role for nitric oxide signaling in neuronal death. Biochimica et Biophysica Acta -General Subj. 2012;1820:736\u201342.","journal-title":"Biochimica et Biophysica Acta -General Subj"},{"key":"3321_CR59","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.bbagen.2014.12.013","volume":"1850","author":"S Okamoto","year":"2015","unstructured":"Okamoto S, Lipton SA. S-Nitrosylation in neurogenesis and neuronal development. Biochimica et Biophysica Acta -General Subj. 2015;1850:1588\u201393.","journal-title":"Biochimica et Biophysica Acta -General Subj"},{"key":"3321_CR60","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/21655979.2020.1867405","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Chen G, He J, Huang ZG, Li SH, Yang YP, et al. Clinical significance and potential molecular mechanism of miRNA-222-3p in metastatic prostate cancer. Bioengineered. 2021;12:325\u201340.","journal-title":"Bioengineered"},{"key":"3321_CR61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/alz.12397","volume":"18","author":"CC Teerlink","year":"2022","unstructured":"Teerlink CC, Miller JB, Vance EL, Staley LA, Stevens J, Tavana JP, et al. Analysis of high\u2010risk pedigrees identifies 11 candidate variants for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2022;18:307\u201317.","journal-title":"Alzheimer\u2019s Dement"},{"key":"3321_CR62","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/tra.12153","volume":"15","author":"PA Vanlandingham","year":"2014","unstructured":"Vanlandingham PA, Barmchi MP, Royer S, Green R, Bao H, Reist N, et al. AP180 couples protein retrieval to clathrin\u2010mediated endocytosis of synaptic vesicles. Traffic. 2014;15:433\u201350.","journal-title":"Traffic"},{"key":"3321_CR63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fnana.2015.00023","volume":"9","author":"\u00c9 Vigneault","year":"2015","unstructured":"Vigneault \u00c9, Poirel O, Riad M, Prud\u2019Homme J, Dumas S, Turecki G, et al. Distribution of vesicular glutamate transporters in the human brain. Front Neuroanat. 2015;9:23.","journal-title":"Front Neuroanat"},{"key":"3321_CR64","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.neuron.2013.05.005","volume":"78","author":"T Nakamura","year":"2013","unstructured":"Nakamura T, Tu S, Akhtar MW, Sunico CR, Okamoto S, Lipton SA. Aberrant protein s-nitrosylation in neurodegenerative diseases. Neuron. 2013;78:596\u2013614.","journal-title":"Neuron"},{"key":"3321_CR65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/(SICI)1097-4547(19991001)58:1<107::AID-JNR11>3.0.CO;2-G","volume":"58","author":"D Gerendasy","year":"1999","unstructured":"Gerendasy D. Homeostatic tuning of Ca2+ signal transduction by members of the calpacitin protein family. J Neurosci Res. 1999;58:107\u201319.","journal-title":"J Neurosci Res"},{"key":"3321_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S1041610298005110","volume":"10","author":"P Davidsson","year":"1998","unstructured":"Davidsson P, Blennow K. Neurochemical dissection of synaptic pathology in Alzheimer\u2019s disease. Int Psychogeriatr. 1998;10:11\u201323.","journal-title":"Int Psychogeriatr"},{"key":"3321_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2010.09.073","volume":"1362","author":"A Thorsell","year":"2010","unstructured":"Thorsell A, Bjerke M, Gobom J, Brunhage E, Vanmechelen E, Andreasen N, et al. Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer\u2019s disease. Brain Res. 2010;1362:13\u201322.","journal-title":"Brain Res"},{"key":"3321_CR68","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s12031-021-01792-z","volume":"71","author":"W Hamoudi","year":"2021","unstructured":"Hamoudi W, von Lendenfeld F, Kartawy M, Mencer S, Suloh H, Khaliulin I, et al. Regional differences in S-nitrosylation in the cortex, striatum, and hippocampus of juvenile male mice. J Mol Neurosci. 2021;71:2383\u201392.","journal-title":"J Mol Neurosci"},{"key":"3321_CR69","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1523\/JNEUROSCI.10-12-03782.1990","volume":"10","author":"A Represa","year":"1990","unstructured":"Represa A, Deloulme JC, Sensenbrenner M, Ben-Ari Y, Baudier J. Neurogranin: immunocytochemical localization of a brain-specific protein kinase C substrate. J Neurosci. 1990;10:3782\u201392.","journal-title":"J Neurosci"},{"key":"3321_CR70","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrm2764","volume":"10","author":"M Benhar","year":"2009","unstructured":"Benhar M, Forrester MT, Stamler JS. Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol. 2009;10:721\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3321_CR71","doi-asserted-by":"publisher","first-page":"ra68","DOI":"10.1126\/scisignal.aaa4312","volume":"8","author":"K Raju","year":"2015","unstructured":"Raju K, Doulias PT, Evans P, Krizman EN, Jackson JG, Horyn O, et al. Regulation of brain glutamate metabolism by nitric oxide and S-nitrosylation. Sci Signal. 2015;8:ra68.","journal-title":"Sci Signal"},{"key":"3321_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4062\/biomolther.2015.078","volume":"24","author":"N Wu","year":"2016","unstructured":"Wu N, Yang M, Gaur U, Xu H, Yao Y, Li D. Alpha-ketoglutarate: physiological functions and applications. Biomolecules Ther. 2016;24:1.","journal-title":"Biomolecules Ther"},{"key":"3321_CR73","doi-asserted-by":"publisher","first-page":"9782346","DOI":"10.1155\/2016\/9782346","volume":"2016","author":"L Sobrevia","year":"2016","unstructured":"Sobrevia L, Ooi L, Ryan S, Steinert JR. Nitric oxide: a regulator of cellular function in health and disease. Oxid Med Cell Longev. 2016;2016:9782346.","journal-title":"Oxid Med Cell Longev"},{"key":"3321_CR74","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1111\/j.1460-9568.2012.08234.x","volume":"36","author":"E Beamer","year":"2012","unstructured":"Beamer E, Otahal J, Sills GJ, Thippeswamy T. N w\u2010Propyl\u2010l\u2010arginine (L\u2010NPA) reduces status epilepticus and early epileptogenic events in a mouse model of epilepsy: behavioural, EEG and immunohistochemical analyses. Eur J Neurosci. 2012;36:3194\u2013203.","journal-title":"Eur J Neurosci"},{"key":"3321_CR75","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1001\/archneur.56.12.1449","volume":"56","author":"WR Markesbery","year":"1999","unstructured":"Markesbery WR. The role of oxidative stress in Alzheimer disease. Arch Neurol. 1999;56:1449\u201352.","journal-title":"Arch Neurol"},{"key":"3321_CR76","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.niox.2009.03.001","volume":"20","author":"L Zhou","year":"2009","unstructured":"Zhou L, Zhu DY. Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide. 2009;20:223\u201330.","journal-title":"Nitric Oxide"},{"key":"3321_CR77","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.lfs.2003.10.042","volume":"75","author":"F Aktan","year":"2004","unstructured":"Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci. 2004;75:639\u201353.","journal-title":"Life Sci"},{"key":"3321_CR78","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer\u2019s disease. Neurobiol Aging. 2000;21:383\u2013421.","journal-title":"Neurobiol Aging"},{"key":"3321_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-8-2","volume":"8","author":"WA Eimer","year":"2013","unstructured":"Eimer WA, Vassar R. Neuron loss in the 5XFAD mouse model of Alzheimer\u2019s disease correlates with intraneuronal A\u03b242 accumulation and Caspase-3 activation. Mol Neurodegener. 2013;8:1\u201312.","journal-title":"Mol Neurodegener"},{"key":"3321_CR80","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nn1503","volume":"8","author":"EM Snyder","year":"2005","unstructured":"Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, et al. Regulation of NMDA receptor trafficking by amyloid-\u03b2. Nat Neurosci. 2005;8:1051\u20138.","journal-title":"Nat Neurosci"},{"key":"3321_CR81","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic function of tau mediates amyloid-\u03b2 toxicity in Alzheimer\u2019s disease mouse models. Cell. 2010;142:387\u201397.","journal-title":"Cell"},{"key":"3321_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2014.08.014","volume":"36","author":"A Stargardt","year":"2015","unstructured":"Stargardt A, Swaab DF, Bossers K. The storm before the quiet: neuronal hyperactivity and A\u03b2 in the presymptomatic stages of Alzheimer\u2019s disease. Neurobiol Aging. 2015;36:1\u201311.","journal-title":"Neurobiol Aging"},{"key":"3321_CR83","doi-asserted-by":"publisher","first-page":"e50333","DOI":"10.7554\/eLife.50333","volume":"8","author":"S Ghatak","year":"2019","unstructured":"Ghatak S, Dolatabadi N, Trudler D, Zhang X, Wu Y, Mohata M, et al. Mechanisms of hyperexcitability in Alzheimer\u2019s disease hiPSC-derived neurons and cerebral organoids vs isogenic controls. eLife. 2019;8:e50333.","journal-title":"eLife"},{"key":"3321_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0213-9","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang Y, Wu Z, Bai YT, Wu GY, Chen G. Gad67 haploinsufficiency reduces amyloid pathology and rescues olfactory memory deficits in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2017;12:1\u201315.","journal-title":"Mol Neurodegener"},{"key":"3321_CR85","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-Balado J, Eich TS, editors. GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer\u2019s disease. Seminars in cell & developmental biology; 2021: Elsevier.","DOI":"10.1016\/j.semcdb.2021.01.005"},{"key":"3321_CR86","doi-asserted-by":"publisher","first-page":"e11058","DOI":"10.7554\/eLife.11058","volume":"5","author":"B Carroll","year":"2016","unstructured":"Carroll B, Maetzel D, Maddocks OD, Otten G, Ratcliff M, Smith GR, et al. Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity. eLife. 2016;5:e11058.","journal-title":"eLife"},{"key":"3321_CR87","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.tibs.2006.04.003","volume":"31","author":"I Ruvinsky","year":"2006","unstructured":"Ruvinsky I, Meyuhas O. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochemical Sci. 2006;31:342\u20138.","journal-title":"Trends Biochemical Sci"},{"key":"3321_CR88","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1128\/MCB.24.8.3112-3124.2004","volume":"24","author":"M Pende","year":"2004","unstructured":"Pende M, Um SH, Mieulet V, Sticker M, Goss VL, Mestan J, et al. S6K1\u2212\/\u2212\/S6K2\u2212\/\u2212 mice exhibit perinatal lethality and rapamycin-sensitive 5\u2032-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol. 2004;24:3112\u201324.","journal-title":"Mol Cell Biol"},{"key":"3321_CR89","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1101\/lm.044974.117","volume":"24","author":"PS Pirbhoy","year":"2017","unstructured":"Pirbhoy PS, Farris S, Steward O. Synaptically driven phosphorylation of ribosomal protein S6 is differentially regulated at active synapses versus dendrites and cell bodies by MAPK and PI3K\/mTOR signaling pathways. Learn Mem. 2017;24:341\u201357.","journal-title":"Learn Mem"},{"key":"3321_CR90","doi-asserted-by":"publisher","first-page":"8688","DOI":"10.1074\/jbc.M110.141754","volume":"286","author":"JA Hutchinson","year":"2011","unstructured":"Hutchinson JA, Shanware NP, Chang H, Tibbetts RS. Regulation of ribosomal protein S6 phosphorylation by casein kinase 1 and protein phosphatase 1. J Biol Chem. 2011;286:8688\u201396.","journal-title":"J Biol Chem"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03321-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03321-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03321-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T09:24:34Z","timestamp":1743326674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03321-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3321"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03321-7","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HA is a CSO of Point6 Bio and Neuro-NOS. No funds from both companies were received for this study. All other authors do not hold any competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}